Health Boards
Mon-08-09-2014, 23:07 PM
That makes some interesting reading it's clear to see which way the major companies are going and it's good to read of the projected increase in use by 2023.
Perhaps by then doctors will stop dishing out steroid creams and methotrexate so readily .
It's good to see the biosimilars are likely to be launched in the next few years, hopefully bringing the cost of treatments down significantly
Perhaps by then doctors will stop dishing out steroid creams and methotrexate so readily .
It's good to see the biosimilars are likely to be launched in the next few years, hopefully bringing the cost of treatments down significantly
